Epigenomic analysis of Alu repeats in human ependymomas

Hehuang Xie, Min Wang, Maria De F Bonaldo, Veena Rajaram, Wendy Stellpflug, Christina Smith, Kelly Arndt, Stewart Goldman, Tadanori Tomita, Marcelo B. Soares

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Global loss of DNA methylation has been known for decades as an epigenomic aberration associated with carcinogenesis and cancer progression. Loss of DNA methylation affects predominantly repetitive elements, which encompass >50% of the CpG dinucleotides present in the human genome. Because of the lack of an effective approach, no studies have been conducted to reveal such genome-wide methylation changes at a single-base resolution. To precisely determine the CpG sites with methylation loss during progression of pediatric intracranial ependymomas, we exploited a high-throughput bisulfite sequencing approach that simultaneously generates methylation profiles for thousands of Alu elements and their flanking sequences. Comparison of the methylation profiles of normal and tumor tissues revealed that the methylation status of the majority of CpG sites adjacent to or within Alu repeats remain unaltered, while a small set of CpG sites gain or lose methylation in ependymomas. Compared to the CpG sites with stable methylation level between normal control and ependymomas, the differentially methylated CpG sites are enriched in the sequences with low CpG density in the flanking regions of Alu repeats, rather than within the Alu sequences themselves. In addition, the CpG sites that are hypermethylated in ependymomas are proximal to CpG islands, whereas those that are hypomethylated are overrepresented in intergenic regions. Lastly, aberrant methylation of several genomic loci was confirmed to be associated with the aggressive primary tumors and the relapsed ependymomas.

Original languageEnglish (US)
Pages (from-to)6952-6957
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume107
Issue number15
DOIs
StatePublished - Apr 13 2010

Fingerprint

Ependymoma
Epigenomics
Methylation
DNA Methylation
Alu Elements
Neoplasms
CpG Islands
Intergenic DNA
Human Genome
Carcinogenesis
Genome
Pediatrics

Keywords

  • Bisulfite sequencing
  • DNA methylation
  • Pediatric brain tumor

ASJC Scopus subject areas

  • General

Cite this

Epigenomic analysis of Alu repeats in human ependymomas. / Xie, Hehuang; Wang, Min; Bonaldo, Maria De F; Rajaram, Veena; Stellpflug, Wendy; Smith, Christina; Arndt, Kelly; Goldman, Stewart; Tomita, Tadanori; Soares, Marcelo B.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, No. 15, 13.04.2010, p. 6952-6957.

Research output: Contribution to journalArticle

Xie, H, Wang, M, Bonaldo, MDF, Rajaram, V, Stellpflug, W, Smith, C, Arndt, K, Goldman, S, Tomita, T & Soares, MB 2010, 'Epigenomic analysis of Alu repeats in human ependymomas', Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 15, pp. 6952-6957. https://doi.org/10.1073/pnas.0913836107
Xie, Hehuang ; Wang, Min ; Bonaldo, Maria De F ; Rajaram, Veena ; Stellpflug, Wendy ; Smith, Christina ; Arndt, Kelly ; Goldman, Stewart ; Tomita, Tadanori ; Soares, Marcelo B. / Epigenomic analysis of Alu repeats in human ependymomas. In: Proceedings of the National Academy of Sciences of the United States of America. 2010 ; Vol. 107, No. 15. pp. 6952-6957.
@article{a10179cd5e094c23bb983411c27a71bf,
title = "Epigenomic analysis of Alu repeats in human ependymomas",
abstract = "Global loss of DNA methylation has been known for decades as an epigenomic aberration associated with carcinogenesis and cancer progression. Loss of DNA methylation affects predominantly repetitive elements, which encompass >50{\%} of the CpG dinucleotides present in the human genome. Because of the lack of an effective approach, no studies have been conducted to reveal such genome-wide methylation changes at a single-base resolution. To precisely determine the CpG sites with methylation loss during progression of pediatric intracranial ependymomas, we exploited a high-throughput bisulfite sequencing approach that simultaneously generates methylation profiles for thousands of Alu elements and their flanking sequences. Comparison of the methylation profiles of normal and tumor tissues revealed that the methylation status of the majority of CpG sites adjacent to or within Alu repeats remain unaltered, while a small set of CpG sites gain or lose methylation in ependymomas. Compared to the CpG sites with stable methylation level between normal control and ependymomas, the differentially methylated CpG sites are enriched in the sequences with low CpG density in the flanking regions of Alu repeats, rather than within the Alu sequences themselves. In addition, the CpG sites that are hypermethylated in ependymomas are proximal to CpG islands, whereas those that are hypomethylated are overrepresented in intergenic regions. Lastly, aberrant methylation of several genomic loci was confirmed to be associated with the aggressive primary tumors and the relapsed ependymomas.",
keywords = "Bisulfite sequencing, DNA methylation, Pediatric brain tumor",
author = "Hehuang Xie and Min Wang and Bonaldo, {Maria De F} and Veena Rajaram and Wendy Stellpflug and Christina Smith and Kelly Arndt and Stewart Goldman and Tadanori Tomita and Soares, {Marcelo B.}",
year = "2010",
month = "4",
day = "13",
doi = "10.1073/pnas.0913836107",
language = "English (US)",
volume = "107",
pages = "6952--6957",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "15",

}

TY - JOUR

T1 - Epigenomic analysis of Alu repeats in human ependymomas

AU - Xie, Hehuang

AU - Wang, Min

AU - Bonaldo, Maria De F

AU - Rajaram, Veena

AU - Stellpflug, Wendy

AU - Smith, Christina

AU - Arndt, Kelly

AU - Goldman, Stewart

AU - Tomita, Tadanori

AU - Soares, Marcelo B.

PY - 2010/4/13

Y1 - 2010/4/13

N2 - Global loss of DNA methylation has been known for decades as an epigenomic aberration associated with carcinogenesis and cancer progression. Loss of DNA methylation affects predominantly repetitive elements, which encompass >50% of the CpG dinucleotides present in the human genome. Because of the lack of an effective approach, no studies have been conducted to reveal such genome-wide methylation changes at a single-base resolution. To precisely determine the CpG sites with methylation loss during progression of pediatric intracranial ependymomas, we exploited a high-throughput bisulfite sequencing approach that simultaneously generates methylation profiles for thousands of Alu elements and their flanking sequences. Comparison of the methylation profiles of normal and tumor tissues revealed that the methylation status of the majority of CpG sites adjacent to or within Alu repeats remain unaltered, while a small set of CpG sites gain or lose methylation in ependymomas. Compared to the CpG sites with stable methylation level between normal control and ependymomas, the differentially methylated CpG sites are enriched in the sequences with low CpG density in the flanking regions of Alu repeats, rather than within the Alu sequences themselves. In addition, the CpG sites that are hypermethylated in ependymomas are proximal to CpG islands, whereas those that are hypomethylated are overrepresented in intergenic regions. Lastly, aberrant methylation of several genomic loci was confirmed to be associated with the aggressive primary tumors and the relapsed ependymomas.

AB - Global loss of DNA methylation has been known for decades as an epigenomic aberration associated with carcinogenesis and cancer progression. Loss of DNA methylation affects predominantly repetitive elements, which encompass >50% of the CpG dinucleotides present in the human genome. Because of the lack of an effective approach, no studies have been conducted to reveal such genome-wide methylation changes at a single-base resolution. To precisely determine the CpG sites with methylation loss during progression of pediatric intracranial ependymomas, we exploited a high-throughput bisulfite sequencing approach that simultaneously generates methylation profiles for thousands of Alu elements and their flanking sequences. Comparison of the methylation profiles of normal and tumor tissues revealed that the methylation status of the majority of CpG sites adjacent to or within Alu repeats remain unaltered, while a small set of CpG sites gain or lose methylation in ependymomas. Compared to the CpG sites with stable methylation level between normal control and ependymomas, the differentially methylated CpG sites are enriched in the sequences with low CpG density in the flanking regions of Alu repeats, rather than within the Alu sequences themselves. In addition, the CpG sites that are hypermethylated in ependymomas are proximal to CpG islands, whereas those that are hypomethylated are overrepresented in intergenic regions. Lastly, aberrant methylation of several genomic loci was confirmed to be associated with the aggressive primary tumors and the relapsed ependymomas.

KW - Bisulfite sequencing

KW - DNA methylation

KW - Pediatric brain tumor

UR - http://www.scopus.com/inward/record.url?scp=77951028452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951028452&partnerID=8YFLogxK

U2 - 10.1073/pnas.0913836107

DO - 10.1073/pnas.0913836107

M3 - Article

C2 - 20351280

AN - SCOPUS:77951028452

VL - 107

SP - 6952

EP - 6957

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 15

ER -